Back to Robeco Institutional Asset Management B.V. Robeco Institutional Asset Management B.V.

LGNDLGND
8 quarters

Position history for Robeco Institutional Asset Management B.V.Robeco Institutional Asset Management B.V.'s holdings in LIGAND PHARMACEUTICALS

Robeco Institutional Asset Management B.V. previously held 0 shares of LGND (LIGAND PHARMACEUTICALS), worth $0 as of 2024-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$237,942

Total Shares Change

-3,562

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$97.37
0
2024-Q2
Unchanged
3,694
0.0%
$311,2560.0%$84.26
0
2024-Q1
Unchanged
3,694
0.0%
$270,0310.0%$73.10
0
2023-Q4
Increased
3,694
+3.7%
$263,8250.0%$71.42
24
2023-Q3
Decreased
3,562
-37.5%
$213,4350.0%$59.92
0
2023-Q2
Increased
5,701
+60.0%
$411,0420.0%$72.60
34
2023-Q1
Unchanged
3,562
0.0%
$262,0210.0%$71.40
0
2022-Q4
New
3,562
-
$237,9420.0%$66.80
32

Other major holders of LGND: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used